Description
BSE clarifications from Thyrocare Technologies Limited and Hemisphere Properties India Limited regarding significant movement in share volume and price.
Summary
BSE sought clarifications from two companies - Thyrocare Technologies Limited (Scrip Code: 539871) and Hemisphere Properties India Limited (Scrip Code: 543242) - regarding significant movement in share volume and price. Both companies responded on November 14, 2025, confirming they have no undisclosed material information and attributing the movements to purely market-driven factors.
Key Points
- Thyrocare Technologies Limited clarified significant increase in volume across exchanges
- Hemisphere Properties India Limited clarified spurt in volume (query received November 13-14, 2025)
- Both companies confirmed timely disclosure of all material information under Regulation 30 of SEBI Listing Regulations
- Management of both companies stated they are not connected with the volume/price increases
- No pending announcements or unpublished price sensitive information at either company
- Movements attributed to purely market-driven factors
Regulatory Changes
No regulatory changes announced. This is a standard surveillance clarification process.
Compliance Requirements
- Companies confirmed compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Both companies maintain Materiality Policy as required under the Listing Regulations
- Timely and appropriate disclosures made in accordance with Board-approved guidelines
Important Dates
- November 13, 2025: BSE sought clarification from Hemisphere Properties India Limited
- November 14, 2025: BSE sought clarification from Thyrocare Technologies Limited (Ref. No: L/SURV/ONL/PV/AA/2025-2026/678)
- November 14, 2025: Both companies responded with clarifications
Impact Assessment
Market Impact: Low - Routine surveillance clarifications with no material undisclosed information
Investor Impact: Low - Provides transparency that volume/price movements are market-driven with no underlying corporate developments
Operational Impact: None - No operational changes or pending announcements from either company
Compliance Impact: Demonstrates active surveillance by BSE and compliance adherence by listed companies
Impact Justification
Routine surveillance clarifications where both companies confirmed no undisclosed material information and attributed volume/price movements to market-driven factors